Trump Administration Readies Potential 100% Tariffs on Pharmaceuticals from Companies Without Agreements: Report
Pharmaceutical Tariffs: Pharmaceutical companies from the EU, Japan, South Korea, Switzerland, and the UK will face separate tariff rates under bilateral deals with the U.S., with potential new tariffs announced as early as Thursday, possibly reaching up to 100% on certain drugs.
Exemptions for Generic Drugs: The new tariffs will not apply to generic drugs, which will be exempt from any additional tariffs, allowing companies to avoid these costs if they relocate manufacturing to the U.S. or negotiate deals with the Trump administration.
Major Pharmaceutical Agreements: Several major pharmaceutical companies have already struck deals with the Trump administration to lower drug prices for American patients, including agreements from companies like Eli Lilly and Pfizer.
Market Reactions: As of the time of reporting, major pharmaceutical ETFs were down about 1%, reflecting market sentiment amid the impending tariff announcements and ongoing negotiations regarding drug pricing.
Trade with 70% Backtested Accuracy
Analyst Views on SPY
About the author

- Iran's Negotiation Stance: Iran is not in a rush to engage in negotiations, indicating a strategic approach to its diplomatic relations.
- Source of Information: The information comes from a source identified as "Iran's Tasnim," suggesting a state-affiliated perspective on the matter.
U.S.-Iran Talks: U.S. Vice President Pence played a crucial role in facilitating upcoming U.S.-Iran talks set to begin in Islamabad, Pakistan, with expectations of several days of negotiations to finalize a ceasefire agreement.
Pakistan's Involvement: Pakistani officials are advocating for Pence to extend his stay in Pakistan to assist in the negotiation efforts.
Iran's Distrust: A senior official from the Gulf region revealed that Iran has minimal trust in U.S. President Trump's envoy, Witkoff, who has previously led multiple rounds of talks with Iran that were disrupted by U.S. military strikes.
Witkoff's Role: Witkoff is part of the U.S. delegation participating in the talks in Islamabad, indicating ongoing diplomatic efforts despite past tensions.

Market Recovery: U.S. major indexes have reversed previous losses and are trending higher.
Trump's Influence: Donald Trump has urged Israel to reduce its military strikes on Lebanon.

Federal Reserve Chair Announcement: The White House has announced that a new Federal Reserve Chair will be appointed in May.
Economic Advisor's Confidence: The economic advisor expressed confidence in the upcoming leadership change at the Federal Reserve.

Current Economic Outlook: Mary Daly, President of the San Francisco Federal Reserve, stated that the U.S. economy remains strong with ongoing consumer spending and business investments, despite concerns about inflation and the impact of the ongoing war in the Middle East.
Inflation and Interest Rates: There is a growing concern among policymakers about potential interest rate hikes if inflation remains above the 2% target, particularly in light of inflationary pressures linked to the U.S.-Israel conflict.
Labor Market Stability: Daly noted that while there are concerns about the labor market's solidity, it appears to be stabilizing, contributing positively to the overall economic outlook.
Market Reactions: Recent market data showed gains in major ETFs tracking the S&P 500, while oil-related funds experienced declines, reflecting investor sentiment amid geopolitical tensions and economic forecasts.









